[go: up one dir, main page]

TR200604349A2 - Aripiprazol içeren farmasötik bileşimler - Google Patents

Aripiprazol içeren farmasötik bileşimler

Info

Publication number
TR200604349A2
TR200604349A2 TR2006/04349A TR200604349A TR200604349A2 TR 200604349 A2 TR200604349 A2 TR 200604349A2 TR 2006/04349 A TR2006/04349 A TR 2006/04349A TR 200604349 A TR200604349 A TR 200604349A TR 200604349 A2 TR200604349 A2 TR 200604349A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
compositions containing
aripiprazole
containing aripiprazole
disintegrant
Prior art date
Application number
TR2006/04349A
Other languages
English (en)
Inventor
Uslu Abdullah
Original Assignee
NOBEL İLAÇ SANAYii VE TiCARET A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39082470&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200604349(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by NOBEL İLAÇ SANAYii VE TiCARET A.Ş. filed Critical NOBEL İLAÇ SANAYii VE TiCARET A.Ş.
Priority to TR2006/04349A priority Critical patent/TR200604349A2/tr
Priority to PCT/TR2007/000076 priority patent/WO2008020820A2/en
Priority to EP07835588.0A priority patent/EP2051694B1/en
Publication of TR200604349A2 publication Critical patent/TR200604349A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Buluş konusu uygun dissolüsyon ve stabilite değerlerine sahip aripiprazol tablet formülasyonu, aripiprazol etken maddesini veya farmasötik açıdan uygun bir tuzunu ve yardımcı madde olarak en az bir dolgu maddesini, en az bir dağıtıcıyı, en az bir bağlayıcıyı ve en az bir kaydırıcı içermektedir.
TR2006/04349A 2006-08-15 2006-08-15 Aripiprazol içeren farmasötik bileşimler TR200604349A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2006/04349A TR200604349A2 (tr) 2006-08-15 2006-08-15 Aripiprazol içeren farmasötik bileşimler
PCT/TR2007/000076 WO2008020820A2 (en) 2006-08-15 2007-08-15 Pharmaceutical compositions comprising aripiprazole
EP07835588.0A EP2051694B1 (en) 2006-08-15 2007-08-15 Pharmaceutical compositions comprising aripiprazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2006/04349A TR200604349A2 (tr) 2006-08-15 2006-08-15 Aripiprazol içeren farmasötik bileşimler

Publications (1)

Publication Number Publication Date
TR200604349A2 true TR200604349A2 (tr) 2008-03-21

Family

ID=39082470

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2006/04349A TR200604349A2 (tr) 2006-08-15 2006-08-15 Aripiprazol içeren farmasötik bileşimler

Country Status (3)

Country Link
EP (1) EP2051694B1 (tr)
TR (1) TR200604349A2 (tr)
WO (1) WO2008020820A2 (tr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799790B2 (en) 2006-07-20 2010-09-21 Helm Ag Amorphous aripiprazole and process for the preparation thereof
EP1880714A1 (en) 2006-07-20 2008-01-23 Helm AG Amorphous Aripiprazole and Process for the Preparation thereof
TR201000948A1 (tr) * 2010-02-09 2011-08-22 Sanovel İlaç San.Ve Ti̇c.A.Ş. Aripiprazol formülasyonları.
WO2013100878A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Pharmaceutical formulations comprising aripiprazole
WO2014104989A1 (en) * 2011-12-27 2014-07-03 Mahmut Bilgic Pharmaceutical compositions comprising aripiprazole
WO2013175508A2 (en) * 2012-05-24 2013-11-28 Medreich Limited Stable pharmaceutical composition of aripiprazole
GR1008186B (el) 2013-04-22 2014-05-08 "Φαρματεν Α.Β.Ε.Ε.", Φαρμακευτικο σκευασμα περιεχον ενα ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου
US9051268B2 (en) 2013-04-30 2015-06-09 Otsuka Pharmaceutical Co., Ltd. Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole
EP2838513B1 (en) * 2013-04-30 2017-04-05 Otsuka Pharmaceutical Co., Ltd. Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole
US20150093441A1 (en) * 2013-09-30 2015-04-02 Otsuka Pharmaceutical Co., Ltd Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole
GR1008442B (el) 2014-01-16 2015-03-05 "Φαρματεν Α.Β.Ε.Ε.", Φαρμακευτικο σκευασμα περιεχον αριπιπραζολη ή αλας αυτης
WO2016189504A1 (en) * 2015-05-28 2016-12-01 Leiutis Pharmaceuticals Pvt Ltd Non-lyophilized compositions of aripiprazole and methods of preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
WO2003030868A1 (en) 2001-10-09 2003-04-17 Bristol-Myers Squibb Company Flashmelt oral dosage formulation
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
NZ546063A (en) * 2003-10-23 2009-05-31 Otsuka Pharma Co Ltd Controlled release sterile injectable aripiprazole (7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]-butoxy]-3,4-dihydro-2(1H)-quinolinone) formulation and method
CN100336509C (zh) 2004-06-18 2007-09-12 成都康弘科技实业（集团）有限公司 阿立哌唑的口腔崩解片制剂及其制备方法
WO2006097344A1 (en) 2005-03-17 2006-09-21 Synthon B.V. Pharmaceutical tablets of crystalline type ii aripiprazole
EP2036545A1 (en) 2006-01-05 2009-03-18 Teva Pharmaceutical Industries Ltd. Aripiprazole tablets
JP2008531738A (ja) 2006-01-05 2008-08-14 テバ ファーマシューティカル インダストリーズ リミティド アリピプラゾールの乾燥製剤

Also Published As

Publication number Publication date
WO2008020820A3 (en) 2008-05-29
EP2051694A2 (en) 2009-04-29
WO2008020820A2 (en) 2008-02-21
EP2051694B1 (en) 2017-10-18

Similar Documents

Publication Publication Date Title
TR200604349A2 (tr) Aripiprazol içeren farmasötik bileşimler
MX2010004222A (es) Formulaciones solidas de compuestos cristalinos.
PH12013502277A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4 methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
CR20110110A (es) Composicion farmaceutica
EA201290984A1 (ru) Гелеобразные фармацевтические композиции, препятствующие злоупотреблению
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
FR2949062B1 (fr) Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
IL192298A (en) Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them
ATE540680T1 (de) Pharmazeutische aripiprazol-zusammensetzungen
WO2009024611A3 (en) 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use
TN2012000371A1 (en) Pyrazole compounds as crth2 antagonists
EP2197858A4 (en) 1,3,5-TRIAZIN-2,4,6-TRIAMIN COMPOUND OR PHARMACEUTICAL ACCEPTABLE SALT, AND PHARMACEUTICAL COMPOSITION THEREWITH
MX343358B (es) Tabletas de acetato de ulipristal.
CL2007003265A1 (es) Compuestos derivados de 1h-piran[2,3-d]pirimidin-2,4,7-triona; y composicion farmaceutica, util para el tratamiento de sindrome metabolico, dislipidemia y enfermedades cardiovasculares entre otras.
PH12013500289A1 (en) Nalbuphine-based formulations and uses thereof
WO2007090661A3 (en) Active substance combination comprising azolylcarbinol compounds
MY152885A (en) Medicament containing fluoroquinolones
EP1900368A4 (en) TABLET WITH A SPIRIT OF SOLUBLE ACTIVE SUBSTANCE
WO2009120389A8 (en) Oral and injectable formulations of tetracycline compounds
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
GEP20135859B (en) Stable combined pharmaceutical composition
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
EP1584335A3 (en) Active substance combination comprising a carbinol composition and an opioid
BRPI0810192A2 (pt) Aspartato do ácido 1-ciclopropil-6-fluoro-7-(8-metoxiimino-2,6-diazaespir o [3,4] oct-6-il)-4-oxo-1,4-diidro- [1,8] naftiridina-3-carboxílico, método para preparação do mesmo e composição farmacêutica antimicrobiana compreendendo o mesmo.